Five-factor prognostic model for survival of post-platinum patients with metastatic urothelial carcinoma receiving PD-L1 inhibitors

PURPOSE: A prognostic model for overall survival (OS) of post-platinum patients with metastatic urothelial carcinoma (mUC) receiving PD-1/PD-L1 inhibitors is necessary since existing models were constructed in the chemotherapy setting. MATERIALS AND METHODS: Patient level data were used from phase I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Urol
Main Authors: Sonpavde, Guru, Manitz, Juliane, Gao, Chen, Tayama, Darren, Kaiser, Constanze, Hennessy, Daniel, Makari, Doris, Gupta, Ashok, Abdullah, Shaad Essa, Niegisch, Guenter, Rosenberg, Jonathan E., Bajorin, Dean F., Grivas, Petros, Apolo, Andrea B., Dreicer, Robert, Hahn, Noah M., Galsky, Matthew D., Necchi, Andrea, Srinivas, Sandy, Powles, Thomas, Choueiri, Toni K., Pond, Gregory R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655635/
https://ncbi.nlm.nih.gov/pubmed/32552295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001199
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados